Entremed (ENMD)

[HobGlobulin]

RE: HIF-1 Inhibition

>>The Duke team has completed a phase I trial with a HIF1 inhibitor. "We are actively pursuing this clinically and will be moving this study into Phase 2," Dewhirst said. "We are interested in other applications of HIF-1 inhibition in combination with radiation and chemotherapy for different diseases."<<

Could this be the trial being referred to? (though it doesn't seem to be completed.)


http://clinicaltrials.gov/ct2/results?term=nct00466583